SIG : H1 2022 Investor Presentation

SIG GROUP AG

H1 2022 FINANCIAL RESULTS

CEO SAMUEL SIGRIST

CFO FRANK HERZOG

26 JULY 2022

H1 2022 FINANCIAL RESULTS

DISCLAIMER AND CAUTIONARY STATEMENT

The information contained in this presentation is not for use within any country or jurisdiction or by any persons where such use would constitute a violation of law. If this applies to you, you are not authorised to access or use any such information.

This presentation may contain "forward-looking statements" that are based on our current expectations, assumptions, estimates and projections about us and our industry. Forward-looking statements include, without limitation, any statement that may predict, forecast, indicate or imply future results, performance or achievements, and may contain the words "may", "will", "should", "continue", "believe", "anticipate", "expect", "estimate", "intend", "project", "plan", "will likely continue", "will likely result", or words or phrases with similar meaning. Undue reliance should not be placed on such statements because, by their nature, forward-looking statements involve risks and uncertainties, including, without limitation, economic, competitive, governmental and technological factors outside of the control of SIG Group AG ("SIG", the "Company" or the "Group"), that may cause SIG's business, strategy or actual results to differ materially from the forward-looking statements (or from past results).

For any factors that could cause actual results to differ materially from the forward- looking statements contained in this presentation, please see our offering circular for the issue of notes in June 2020. SIG undertakes no obligation to publicly update or revise any of these forward-looking statements, whether to reflect new information, future events or circumstances or otherwise. It should further be noted that past performance is not a guide to future performance. Persons requiring advice should consult an independent adviser.

While we are making great efforts to include accurate and up-to-date information, we make no representations or warranties, expressed or implied, and no reliance may be placed by any person as to the accuracy and completeness of the information provided in this presentation and we disclaim any liability for the use of it.

Neither SIG nor any of its directors, officers, employees, agents, affiliates or advisers is under an obligation to update, correct or keep current the information contained in this presentation to which it relates or to provide the recipient of it with access to any additional information that may arise in connection with it and any opinions expressed in this presentation are subject to change.

The presentation may not be reproduced, published or transmitted, in whole or in part, directly or indirectly, to any person (whether within or outside such person's organisation or firm) other than its intended recipients.

The attached information is not an offer to sell or a solicitation of an offer to purchase any security in the United States or elsewhere and shall not constitute an offer, solicitation or sale any securities of SIG in any state or jurisdiction in which, or to any person to whom such an offer, solicitation or sale would be unlawful nor shall it or any part of it form the basis of, or be relied on in connection with, any contract or investment decision. No securities may be offered or sold within the United States or to U.S. persons absent registration or an applicable exemption from registration requirements. Any public offering of securities to be made in the United States will be made by means of a prospectus that may be obtained from any issuer of such securities and that will contain detailed information about us. Any failure to comply with the restrictions set out in this paragraph may constitute a violation of the securities laws of any such jurisdiction..

This presentation is not an offer to sell or a solicitation of offers to purchase or subscribe for securities. This document is not a prospectus within the meaning of the Swiss Financial Services Act nor a prospectus under any other applicable laws.

In this presentation, we utilise certain alternative performance measures, including but not limited to EBITDA, adjusted EBITDA, adjusted EBITDA margin, net capex, adjusted net income, free cash flow and net leverage ratio that in each case are not defined in International Financial Reporting Standards ("IFRS").

These alternative non-IFRS measures are presented as we believe that they and similar measures are widely used in the markets in which we operate as a means of evaluating a company's operating performance and financing structure. Our definition of and method of calculating the measures stated above may not be comparable to other similarly titled measures of other companies and are not measurements under IFRS, as issued by the IASB or other generally accepted accounting principles, are not measures of financial condition, liquidity or profitability and should not be considered as an alternative to profit from operations for the period or operating cash flows determined in accordance with IFRS, nor should they be considered as substitutes for the information contained in our consolidated financial statements. You are cautioned not to place undue reliance on any alternative performance measures and ratios not defined in IFRS included in this presentation.

Alternative performance measures

For additional information about alternative performance measures used by management that are not defined in IFRS, including definitions and reconciliations to measures defined in IFRS please refer to this link:

https://www.sig.biz/investors/en/performance/definitions

Some financial information in this presentation has been rounded and, as a result, the figures shown as totals in this presentation may vary slightly from the exact arithmetic aggregation of the figures that precede them.

2

26 JULY 2022

H1 2022 FINANCIAL RESULTS

H1 2022 HIGHLIGHTS

PROVING RESILIENCE IN VOLATILE ENVIRONMENT

STRONG REVENUE GROWTH GLOBALLY

Aseptic carton business delivering robust organic1 growth on top of exceptional H1 2021 performance

Strong contribution from Scholle IPN in June 2022

GROWING CONTRIBUTION FROM PRICE INCREASES ACROSS REGIONS

Top line offsetting raw material cost inflation in Q2

Greater margin benefit from pricing in H2 2022

ACQUISITIONS AND REFINANCING

Scholle IPN completion on 1 June 2022

Evergreen Asia expected to close in Q3

Long term financing for both acquisitions in place

Successful issuance of equity and ESG-linked Schuldschein

SUSTAINABILITY

Increasing on-site renewable energy in Germany - solar panel arrays to be installed in Wittenberg and Linnich plants

Heat recovery system installed at Saalfelden plant in Austria - reducing natural gas consumption by 45% p.a.

Carbon neutral production since 2018

1Organic growth represents SIG revenue growth at constant currency, excluding the impacts of the Scholle IPN acquisition

3

26 JULY 2022

H1 2022 FINANCIAL RESULTS

H1 2022 KEY FIGURES

REVENUE GROWTH

ADJ. EBITDA AHEAD

OF PRIOR YEAR

REVENUE €1,142.6 MILLION

+12.4%

REVENUE GROWTH AT CONSTANT CURRENCY

+7.5%

ORGANIC REVENUE GROWTH1

+18.3%

REPORTED REVENUE GROWTH

ADJUSTED EBITDA

€280.5

MILLION

(H1 2021: €264.1m)

ADJUSTED EBITDA	ADJUSTED NET	FREE CASH FLOW
MARGIN	INCOME
24.6%	€115.0	€(9.4)
(H1 2021: 27.3%)	MILLION	MILLION
	(H1 2021: €109.6m)	(H1 2021: €25.0m)

ADJUSTED

EARNINGS PER

SHARE

€0.33

(H1 2021: €0.33)

1Organic growth represents SIG revenue growth at constant currency, excluding the impacts of the Scholle IPN acquisition

4

26 JULY 2022

H1 2022 FINANCIAL RESULTS

Q2 2022 KEY FIGURES

GROWTH ACCELERATION IN Q2 2022

REVENUE €645.9 MILLION

+17.9%

REVENUE GROWTH AT CONSTANT CURRENCY

+8.8%

ORGANIC REVENUE GROWTH1

+25.5%

REPORTED REVENUE GROWTH

ADJUSTED EBITDA

€161.8

MILLION

(Q2 2021: €146.2m)

ADJUSTED EBITDA	ADJUSTED NET	FREE CASH FLOW
MARGIN	INCOME

25.1%	€74.4	€15.4
(Q2 2021: 28.4%)	MILLION	MILLION
	(Q2 2021: €57.6m)	(Q2 2021: €31.5m)

1Organic growth represents SIG revenue growth at constant currency, excluding the impacts of the Scholle IPN acquisition

5

26 JULY 2022

H1 2022 FINANCIAL RESULTS